When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?
AIDS. 2012 Jun; 26(9):1095-103
Arlene Bardeguez and Dimitry Zilberman
14 Jun 2012
|
Good for Teaching
Data from this interesting study further increase the evidence that starting antiretroviral therapy (ART) as early as possible may be of benefit to decrease HIV mother-to-child transmission (MTCT).
Data on the benefit of ART in decreasing MTCT are widely recognized. A benefit of decreasing viral load to less than 50 HIV RNA copies/ml...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.